Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Eli Lilly and Company (LLY)

-NYSE
61.06 1.56(2.49%) Jul 31, 4:00PM EDT
|After Hours : 61.06 0.00 (0.00%) Jul 31, 5:54PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 23,113,100   22,603,400   24,286,500  
Cost of Revenue4,908,100  4,796,500  5,067,900  
Gross Profit 18,205,000   17,806,900   19,218,600  
Operating Expenses
Research Development5,531,300  5,278,100  5,020,800  
Selling General and Administrative6,606,700  6,839,500  8,058,900  
Non Recurring177,700  281,100  789,400  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 5,889,300   5,408,200   5,349,500  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes5,889,300  5,408,200  5,349,500  
Interest Expense -   -   -  
Income Before Tax5,889,300  5,408,200  5,349,500  
Income Tax Expense1,204,500  1,319,600  1,001,800  
Minority Interest -   -   -  
Net Income From Continuing Ops4,684,800  4,088,600  4,347,700  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 4,684,800   4,088,600   4,347,700  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 4,684,800   4,088,600   4,347,700  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.